{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:17:39Z","timestamp":1792113459904,"version":"4.4.0"},"reference-count":44,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7]]},"abstract":"<jats:title>\n                    A\n                    <jats:sc>BSTRACT<\/jats:sc>\n                  <\/jats:title>\n                  <jats:p>Ketamine is illegally used as a recreational drug in many Asian countries. Long-term ketamine abusers often develop irritable bladder symptoms that gradually develop into more severe urinary frequency and urgency and eventually into a painful ulcerated bladder. These patients typically have reduced functional bladder capacity, increased bladder sensation, detrusor overactivity, severe urgency, urinary incontinence, and bladder contracture. Ketamine metabolites can cause severe inflammation of the urothelium, urothelial barrier deficits, vascular endothelial fibrinoid changes, increased oxidative stress, and bladder wall fibrosis. A decrease in bladder compliance, urinary tract infection, severe bladder pain with a full bladder, and painful micturition are also common symptoms. Finally, with continued abuse of ketamine, hydronephrosis, ureteral stricture, vesicoureteral reflux, and renal failure may develop. Cessation of ketamine is the mainstay of treatment. Lower urinary tract symptoms usually relapse if patients reuse ketamine after stopping. In cases of severe ketamine cystitis, only augmentation enterocystoplasty can relieve bladder pain and restore normal lower urinary tract function. This article reviews the underlying pathophysiology, clinical characteristics, and management of ketamine cystitis.<\/jats:p>","DOI":"10.4103\/tcmj.tcmj_94_23","type":"journal-article","created":{"date-parts":[[2023,6,13]],"date-time":"2023-06-13T04:00:52Z","timestamp":1686628852000},"page":"205-212","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":20,"title":["Pathophysiology, clinical presentation, and management of ketamine-induced cystitis"],"prefix":"10.4103","volume":"35","author":[{"given":"Jia-Fong","family":"Jhang","sequence":"first","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori A.","family":"Birder","sequence":"additional","affiliation":[{"name":"Department of Pharmacology and Chemical Biology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hann-Chorng","family":"Kuo","sequence":"additional","affiliation":[{"name":"Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation and Tzu Chi University, Hualien, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,6,13]]},"reference":[{"key":"R1-20240828","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/02791072.2007.10399861","article-title":"Patterns of ketamine use among young injection drug users","volume":"39","author":"Lankenau","year":"2007","journal-title":"J Psychoactive Drugs"},{"key":"R2-20240828","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.urology.2007.01.038","article-title":"Ketamine-associated ulcerative cystitis:A new clinical entity","volume":"69","author":"Shahani","year":"2007","journal-title":"Urology"},{"key":"R3-20240828","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1111\/j.1464-410X.2008.07920.x","article-title":"The destruction of the lower urinary tract by ketamine abuse:A new syndrome?","volume":"102","author":"Chu","year":"2008","journal-title":"BJU Int"},{"key":"R5-20240828","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.jfma.2011.11.010","article-title":"Ketamine-snorting associated cystitis","volume":"110","author":"Chen","year":"2011","journal-title":"J Formos Med Assoc"},{"key":"R6-20240828","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.urols.2015.07.001","article-title":"Intravesical hyaluronic acid treatment for ketamine-associated cystitis:Preliminary results","volume":"26","author":"Meng","year":"2015","journal-title":"Urol Sci"},{"key":"R7-20240828","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/0300060520973100","article-title":"Comparison of intravesical instillation of hyaluronic acid with intradetrusor botulinum toxin A injection or cystoscopic hydrodistention for ketamine-associated cystitis","volume":"48","author":"Li","year":"2020","journal-title":"J Int Med Res"},{"key":"R8-20240828","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/j.1442-2042.2009.02361.x","article-title":"Ketamine-associated bladder dysfunction","volume":"16","author":"Tsai","year":"2009","journal-title":"Int J Urol"},{"key":"R9-20240828","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.biopsych.2007.02.014","article-title":"Increased response to ketamine following treatment at long intervals:Implications for intermittent use","volume":"63","author":"Trujillo","year":"2008","journal-title":"Biol Psychiatry"},{"key":"R10-20240828","doi-asserted-by":"crossref","first-page":"7240","DOI":"10.1038\/s41598-019-43746-x","article-title":"A survey for ketamine abuse and its relation to the lower urinary tract symptoms in Taiwan","volume":"9","author":"Li","year":"2019","journal-title":"Sci Rep"},{"key":"R11-20240828","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3390\/ijerph17197260","article-title":"Risk of renal function decline in patients with ketamine-associated uropathy","volume":"17","author":"Ou","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"R12-20240828","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1111\/luts.12029","article-title":"Is urodynamic study a good witness to the progression of ketamine-associated cystitis?","volume":"6","author":"Huang","year":"2014","journal-title":"Low Urin Tract Symptoms"},{"key":"R13-20240828","first-page":"310","article-title":"Obstructive nephropathy and kidney injury associated with ketamine abuse","volume":"1","author":"Selby","year":"2008","journal-title":"NDT Plus"},{"key":"R14-20240828","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/iju.12841","article-title":"Possible pathophysiology of ketamine-related cystitis and associated treatment strategies","volume":"22","author":"Jhang","year":"2015","journal-title":"Int J Urol"},{"key":"R15-20240828","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.3892\/mmr.2014.3110","article-title":"Histopathological assessment of inflammation and expression of inflammatory markers in patients with ketamine-induced cystitis","volume":"11","author":"Lin","year":"2015","journal-title":"Mol Med Rep"},{"key":"R16-20240828","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1742-1241.2010.02502.x","article-title":"Ketamine-induced vesicopathy:A literature review","volume":"65","author":"Middela","year":"2011","journal-title":"Int J Clin Pract"},{"key":"R17-20240828","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/ki.2011.242","article-title":"'Walking-stick ureters'in ketamine abuse","volume":"80","author":"Huang","year":"2011","journal-title":"Kidney Int"},{"key":"R18-20240828","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.juro.2011.04.102","article-title":"Involvement of purinergic neurotransmission in ketamine induced bladder dysfunction","volume":"186","author":"Meng","year":"2011","journal-title":"J Urol"},{"key":"R19-20240828","doi-asserted-by":"crossref","first-page":"E343","DOI":"10.36076\/ppj.2010\/13\/E343","article-title":"Ketamine-induced urologic insult (KIUI)","volume":"13","author":"Smith","year":"2010","journal-title":"Pain Physician"},{"key":"R20-20240828","doi-asserted-by":"crossref","first-page":"F318","DOI":"10.1152\/ajprenal.00607.2014","article-title":"Ketamine-induced ulcerative cystitis and bladder apoptosis involve oxidative stress mediated by mitochondria and the endoplasmic reticulum","volume":"309","author":"Liu","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"R21-20240828","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/bju.12256","article-title":"Increased apoptosis and suburothelial inflammation in patients with ketamine-related cystitis:A comparison with non-ulcerative interstitial cystitis and controls","volume":"112","author":"Lee","year":"2013","journal-title":"BJU Int"},{"key":"R22-20240828","doi-asserted-by":"crossref","first-page":"2329868","DOI":"10.1155\/2017\/2329868","article-title":"The Immunomodulatory imbalance in patients with ketamine cystitis","volume":"2017","author":"Fan","year":"2017","journal-title":"Biomed Res Int"},{"key":"R23-20240828","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1002\/nau.23514","article-title":"Histopathological characteristics of ketamine-associated uropathy and their clinical association","volume":"37","author":"Jhang","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"R24-20240828","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/j.juro.2014.05.084","article-title":"Elevated serum IgE may be associated with development of ketamine cystitis","volume":"192","author":"Jhang","year":"2014","journal-title":"J Urol"},{"key":"R25-20240828","doi-asserted-by":"crossref","first-page":"e0160578","DOI":"10.1371\/journal.pone.0160578","article-title":"Microvascular injury in ketamine-induced bladder dysfunction","volume":"11","author":"Lin","year":"2016","journal-title":"PLoS One"},{"key":"R26-20240828","first-page":"O221","article-title":"Vascular fibrinoid necrosis in the urinary bladder of ketamine abusers:A new finding that may provide a clue to the pathogenesis of ketamine-induced vesicopathy","volume":"11","author":"Chen","year":"2019","journal-title":"Low Urin Tract Symptoms"},{"key":"R27-20240828","doi-asserted-by":"crossref","first-page":"197","DOI":"10.5213\/inj.1632634.317","article-title":"Abnormal sensory protein expression and urothelial dysfunction in ketamine-related cystitis in humans","volume":"20","author":"Tsai","year":"2016","journal-title":"Int Neurourol J"},{"key":"R28-20240828","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/2051-5960-1-64","article-title":"Nerve hyperplasia:A unique feature of ketamine cystitis","volume":"1","author":"Baker","year":"2013","journal-title":"Acta Neuropathol Commun"},{"key":"R29-20240828","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1002\/nau.22367","article-title":"Dual involvements of cyclooxygenase and nitric oxide synthase expressions in ketamine-induced ulcerative cystitis in rat bladder","volume":"32","author":"Chuang","year":"2013","journal-title":"Neurourol Urodyn"},{"key":"R30-20240828","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1002\/nau.24139","article-title":"Upregulation of neurotrophins and transforming growth factor-b expression in the bladder may lead to nerve hyperplasia and fibrosis in patients with severe ketamine-associated cystitis","volume":"38","author":"Jhang","year":"2019","journal-title":"Neurourol Urodyn"},{"key":"R31-20240828","doi-asserted-by":"crossref","first-page":"1600085","DOI":"10.1002\/prca.201600085","article-title":"The putative involvement of actin-binding proteins and cytoskeleton proteins in pathological mechanisms of ketamine cystitis-revealed by a prospective pilot study using proteomic approaches","volume":"11","author":"Yang","year":"2017","journal-title":"Proteomics Clin Appl"},{"key":"R32-20240828","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1038\/s41598-021-84734-4","article-title":"Smaller bladder capacity and stronger bladder contractility in patients with ketamine cystitis are associated with elevated TRPV1 and TRPV4","volume":"11","author":"Yang","year":"2021","journal-title":"Sci Rep"},{"key":"R33-20240828","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1016\/j.ajpath.2017.06.004","article-title":"Elucidating mechanisms of bladder repair after hyaluronan instillation in ketamine-induced ulcerative cystitis in animal model","volume":"187","author":"Lee","year":"2017","journal-title":"Am J Pathol"},{"key":"R34-20240828","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.3390\/toxins7062232","article-title":"Novel treatment of chronic bladder pain syndrome and other pelvic pain disorders by onabotulinumtoxinA injection","volume":"7","author":"Jhang","year":"2015","journal-title":"Toxins (Basel)"},{"key":"R35-20240828","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1177\/0300060517693956","article-title":"Effective treatment of ketamine-associated cystitis with botulinum toxin type A injection combined with bladder hydrodistention","volume":"45","author":"Zeng","year":"2017","journal-title":"J Int Med Res"},{"key":"R36-20240828","doi-asserted-by":"crossref","first-page":"5795","DOI":"10.1038\/s41598-018-24239-9","article-title":"Potential orphan drug therapy of intravesical liposomal onabotulinumtoxin-A for ketamine-induced cystitis by mucosal protection and anti-inflammation in a rat model","volume":"8","author":"Lee","year":"2018","journal-title":"Sci Rep"},{"key":"R37-20240828","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/diagnostics10060381","article-title":"Platelet-rich plasma ameliorates cyclophosphamide-induced acute interstitial cystitis\/painful bladder syndrome in a rat model","volume":"10","author":"Chen","year":"2020","journal-title":"Diagnostics (Basel)"},{"key":"R38-20240828","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.5213\/inj.2142100.050","article-title":"Improved urothelial cell proliferation, cytoskeleton and barrier function protein expression in the patients with interstitial cystitis\/bladder pain syndrome after intravesical platelet-rich plasma injection","volume":"26","author":"Jhang","year":"2022","journal-title":"Int Neurourol J"},{"key":"R39-20240828","doi-asserted-by":"crossref","first-page":"5771","DOI":"10.3390\/ijms23105771","article-title":"Therapeutic effect of platelet-rich plasma improves bladder overactivity in the pathogenesis of ketamine-induced ulcerative cystitis in a rat model","volume":"23","author":"Chueh","year":"2022","journal-title":"Int J Mol Sci"},{"key":"R40-20240828","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/nau.22996","article-title":"Patient characteristics for different therapeutic strategies in the management ketamine cystitis","volume":"36","author":"Jhang","year":"2017","journal-title":"Neurourol Urodyn"},{"key":"R41-20240828","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0022-5347(05)64428-X","article-title":"Urinary continence outcome after augmentation ileocystoplasty as a single surgical procedure in patients with myelodysplasia","volume":"168","author":"Medel","year":"2002","journal-title":"J Urol"},{"key":"R42-20240828","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1002\/nau.23339","article-title":"A real-world experience with augmentation enterocystoplasty-high patient satisfaction with high complication rates","volume":"37","author":"Wu","year":"2018","journal-title":"Neurourol Urodyn"},{"key":"R43-20240828","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1002\/nau.22477","article-title":"Augmentation enterocystoplasty is effective in relieving refractory ketamine-related bladder pain","volume":"33","author":"Chung","year":"2014","journal-title":"Neurourol Urodyn"},{"key":"R44-20240828","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1159\/000282974","article-title":"Clinical outcome and quality of life after enterocystoplasty for contracted bladders","volume":"58","author":"Kuo","year":"1997","journal-title":"Urol Int"},{"key":"R45-20240828","first-page":"E431","article-title":"Clinical outcome of augmentation enterocystoplasty for patients with ketamine-induced cystitis","volume":"20","author":"Lee","year":"2017","journal-title":"Pain Physician"}],"container-title":["Tzu Chi Medical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_94_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T16:12:41Z","timestamp":1787760761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/tcmj.tcmj_94_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,13]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.4103\/tcmj.tcmj_94_23","relation":{},"ISSN":["1016-3190","2223-8956"],"issn-type":[{"value":"1016-3190","type":"print"},{"value":"2223-8956","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,13]]},"assertion":[{"value":"2023-04-17","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-05-25","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}